
Phase 3 induction study results show that the drug achieved a positive endoscopic response at week 12

Phase 3 induction study results show that the drug achieved a positive endoscopic response at week 12

Miglustat (Zavesca) is indicated for the treatment of mild to moderate type I Gaucher disease.

Investigators used mouse models and found that the stress hormone suppressed the innate immune system that normally protects the gut from bacteria that is associated with the condition.

Tums treats symptoms such as heartburn, upset stomach, or indigestion.

Milk of Magnesia is a laxative thought to work by drawing water into the intestines, which can cause movement of the intestines.

Dulcolax, for the relief of occasional constipation, contains lactose and sucrose.

MiraLAX is used as a laxative to treat occasional constipation or irregular bowel movements.

Metamucil increases the bulk of stool, an effect that helps to cause movement of the intestines.

How would you answer these patients' questions?

Prilosec treats duodenal ulcer and gastric ulcer in adults, treatment of gastroesophageal reflux disease (GERD) in adults and children, and maintenance of healing of erosive esophagitis.

J&J study results show that ustekinumab was beneficial in treating adults with the 2 types of IBD.

Simethicone is an anti-foaming agent that is taken orally to help reduce the buildup of intestinal and stomach gases that cause bloating and discomfort.

But pharmacists can offer guidance on self-treatment vs more serious issues requiring evaluation.

Bismuth subsalicylate comes as a liquid, tablet, or chewable tablet to treat diarrhea and the symptoms of an upset stomach.

Finding relief can be frustrating and takes effort and time for many patients, but pharmacists can help.

A clear gastrointestinal tract promotes a healthy body and mind and keeps the immune system robust.

The researchers used a body composition analysis of patients with Crohn disease in a collaboration with gastroenterology and surgical specialists.

The study also failed to meet its secondary efficacy endpoints and no new safety signals were observed.

Amisulpride is a selective dopamine-2 and -3 receptor antagonist that inhibits postoperative nausea and vomiting.

Ulcerative colitis and Crohn disease are the two main forms of inflammatory bowel disease.

This month's featured products include empagliflozin, finerenone, and more.

The results of 3 phase 3 trials showed that the drug offered greater proportions of individuals with the condition who met the endpoints of clinical remission and endoscopic response.

For patients with celiac disease, eating gluten triggers an immune response in the small intestine.

Individuals in a study who received the food with BB-12 probiotic retained beneficial metabolites produced by the microbiota.

Crohn disease causes inflammation of the digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.